HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Dominique Bonnefont-Rousselot Selected Research
Dominique Bonnefont-Rousselot Research Topics
Disease
12
Atherosclerosis
12/2021 - 05/2002
11
Inflammation (Inflammations)
01/2022 - 06/2006
11
Fibrosis (Cirrhosis)
01/2020 - 01/2002
6
Cardiovascular Diseases (Cardiovascular Disease)
12/2021 - 10/2011
6
Ischemia
12/2010 - 06/2005
5
Status Epilepticus (Complex Partial Status Epilepticus)
11/2022 - 01/2020
5
Insulin Resistance
05/2018 - 06/2006
5
Metabolic Syndrome (Dysmetabolic Syndrome X)
09/2016 - 11/2006
4
Brain Injuries (Brain Injury)
11/2022 - 09/2004
4
Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
01/2013 - 07/2011
4
Rheumatoid Arthritis
05/2012 - 06/2007
4
Reperfusion Injury
05/2010 - 06/2005
3
Cardiomyopathies (Cardiomyopathy)
01/2020 - 08/2007
3
Liver Cirrhosis (Hepatic Cirrhosis)
01/2020 - 11/2006
3
Myocardial Infarction
01/2018 - 01/2002
3
Heart Failure
01/2016 - 01/2002
3
Weight Loss (Weight Reduction)
01/2014 - 01/2013
3
Portal Hypertension
05/2009 - 11/2006
2
Epilepsy (Aura)
07/2022 - 01/2020
2
Coronary Disease (Coronary Heart Disease)
12/2021 - 01/2017
2
Ascites
01/2020 - 06/2010
2
Type 2 Diabetes Mellitus (MODY)
01/2020 - 06/2005
2
Hypertrophy
01/2020 - 01/2002
2
Hemolysis
01/2020 - 04/2015
2
Pancreatitis
12/2019 - 07/2008
2
Non-alcoholic Fatty Liver Disease
10/2017 - 05/2011
2
Chemical and Drug Induced Liver Injury
01/2017 - 08/2011
2
Obesity Hypoventilation Syndrome (Pickwickian Syndrome)
12/2016 - 11/2015
2
Hyperlipidemias (Hyperlipidemia)
07/2015 - 01/2013
2
Obesity
10/2014 - 01/2014
2
HIV Infections (HIV Infection)
09/2012 - 01/2010
2
Neurodegenerative Diseases (Neurodegenerative Disease)
05/2011 - 11/2010
2
Shock
06/2010 - 12/2007
2
Necrosis
01/2010 - 08/2007
2
Wounds and Injuries (Trauma)
06/2009 - 06/2005
2
Diabetes Complications
04/2009 - 01/2004
2
Osteoarthritis
09/2007 - 06/2007
1
Infarction (Infarctions)
02/2022
1
Schizophrenia (Dementia Praecox)
01/2022
Drug/Important Bio-Agent (IBA)
11
Biomarkers (Surrogate Marker)
IBA
11/2022 - 05/2008
11
Cholesterol
IBA
12/2021 - 03/2008
8
Lipoproteins (Lipoprotein)
IBA
01/2019 - 09/2005
8
oxidized low density lipoprotein
IBA
01/2017 - 05/2002
7
Proteins (Proteins, Gene)
FDA Link
07/2022 - 09/2004
7
Lipids
IBA
12/2021 - 07/2008
7
Triglycerides (Triacylglycerol)
IBA
01/2020 - 06/2006
7
Cytokines
IBA
01/2020 - 01/2002
7
Antioxidants
IBA
05/2018 - 01/2004
5
HDL Cholesterol
IBA
01/2020 - 06/2006
5
HDL Lipoproteins
IBA
09/2016 - 12/2004
5
LDL Lipoproteins (beta Lipoproteins)
IBA
01/2013 - 09/2003
4
Apolipoproteins
IBA
01/2019 - 09/2005
4
LDL Cholesterol
IBA
01/2019 - 01/2009
4
Resveratrol
IBA
05/2016 - 12/2010
4
Melatonin
IBA
01/2014 - 05/2002
4
Superoxides (Superoxide)
IBA
05/2012 - 09/2002
4
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2009 - 06/2005
3
Biological Products
IBA
11/2022 - 01/2009
3
Oxysterols
IBA
01/2022 - 01/2021
3
Oxygen (Dioxygen)
IBA
01/2020 - 04/2008
3
C-Reactive Protein
IBA
09/2018 - 06/2006
3
Troponin T (Troponin T1)
IBA
09/2018 - 04/2015
3
Glutamine (L-Glutamine)
FDA Link
05/2018 - 06/2005
3
Apolipoproteins B (ApoB)
IBA
10/2014 - 01/2009
3
Reactive Oxygen Species (Oxygen Radicals)
IBA
01/2014 - 01/2004
3
Calcium
IBA
05/2010 - 09/2004
3
Nitric Oxide (Nitrogen Monoxide)
FDA Link
05/2009 - 09/2002
2
Phosphopyruvate Hydratase (Enolase)
IBA
07/2022 - 01/2022
2
Progranulins
IBA
07/2022 - 01/2020
2
Troponin
IBA
02/2022 - 01/2018
2
Pharmaceutical Preparations
IBA
01/2022 - 08/2011
2
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
01/2020 - 04/2014
2
Amino Acids
FDA Link
01/2020 - 11/2006
2
Lipase (Acid Lipase)
FDA Link
12/2019 - 04/2015
2
O(4)-methylthymidine triphosphate
IBA
01/2019 - 10/2014
2
Fatty Acids (Saturated Fatty Acids)
IBA
05/2018 - 02/2012
2
Nonesterified Fatty Acids (NEFA)
IBA
05/2018 - 01/2010
2
Glucose (Dextrose)
FDA Link
Generic
05/2018 - 01/2010
2
Insulin (Novolin)
FDA Link
05/2018 - 12/2013
2
Adrenergic Receptors (Adrenergic Receptor)
IBA
01/2017 - 07/2015
2
Adrenergic Agents (Adrenergic Drugs)
IBA
01/2017 - 01/2002
2
Apolipoprotein A-I (Apolipoprotein A1)
IBA
01/2017 - 11/2006
2
Haptoglobins
IBA
01/2017 - 04/2015
2
Leptin
IBA
07/2015 - 01/2010
2
Magnesium
IBA
04/2015 - 01/2004
2
Alanine Transaminase (SGPT)
IBA
04/2015 - 06/2005
2
NADPH Oxidases (NAD(P)H oxidase)
IBA
01/2014 - 05/2012
2
Adipokines
IBA
01/2014 - 01/2010
2
Protease Inhibitors (Protease Inhibitor)
IBA
09/2012 - 01/2010
2
Ritonavir (Norvir)
FDA Link
09/2012 - 01/2010
2
Nitrites
IBA
05/2012 - 09/2005
2
Transaminases (Aminotransferases)
IBA
05/2011 - 07/2008
2
Free Radicals
IBA
05/2010 - 04/2008
2
Interleukin-6 (Interleukin 6)
IBA
01/2010 - 01/2009
2
Vitamin E
FDA Link
Generic
06/2009 - 01/2004
2
Lipopolysaccharides
IBA
01/2009 - 12/2007
2
Thioredoxins
IBA
08/2007 - 06/2007
Therapy/Procedure
3
Therapeutics
01/2013 - 01/2004
2
Blood Component Removal (Apheresis)
01/2017 - 04/2012
2
Ligation
11/2006 - 01/2002